MDExam
US$ 23.66
semaglutide shortage list US FDA says two more doses of Novo Nordisk's weight-loss drug now available semaglutide off fda shortage list
Description
Pharmacy availability affects which formulations can be dispensed at the time of approval
However, there is no official contraindication based solely on heart rate considerations, and these medications can be used safely in most patients with cardiovascular disease under appropriate medical supervision
However, there are differences: brand-name products have extensive clinical trial data, precise manufacturing controls, and FDA approval for specific indications
Treatment decisions should be individualised based on HbA1c levels, cardiovascular and renal risk, patient preferences, and tolerability
